A microfluidic dual gradient generator for conducting cell-based drug combination assays

Area of Science:

• Biotechnology
• Cell Biology
• Microfluidics

Background:

• Drug combination assays are crucial for understanding complex cellular signaling pathways.
• Current methods for assessing drug interactions are often time-consuming and resource-intensive.
• Microfluidic devices offer potential for high-throughput, quantitative cellular analysis.

Purpose of the Study:

• To develop and validate a microfluidic chip capable of generating orthogonally aligned, linear concentration gradients of multiple solutes.
• To demonstrate the utility of this device for live-cell signaling and motility experiments.
• To accelerate the assessment of drug combinatorial interactions in cancer cell models.

Main Methods:

• Fabrication of a microfluidic chip designed for orthogonal gradient generation.
• Characterization of gradient kinetics using fluorescent tracers.
• Live-cell imaging of A431 and MDA-MB-231 cancer cells exposed to multiple drug gradients.
• Monitoring of caspase activation and cellular morphology.

Main Results:

• The microfluidic chip successfully generated stable, linear, and orthogonally aligned concentration gradients.
• Rapid assessment of combinatorial effects of MEK and EGFR inhibitors on A431 cell apoptosis was achieved.
• Quantitative analysis of MDA-MB-231 cell motility and morphology under dual-gradient stimulation was performed.

Conclusions:

• The developed microfluidic device significantly facilitates and accelerates in vitro cell biology experiments.
• This technology is particularly valuable for cell-based drug combination assays, enabling efficient screening and mechanistic studies.
• The chip allows for simultaneous quantitative and morphological characterization of cells under complex chemical stimuli.